Birdwatch Note
2024-09-30 20:52:52 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
帯状疱疹の患者数は複数の国地域でモニタリングされており日本を含め各先進国で21,22年共にコロナ禍前より減少しています 出典 日本の宮崎スタディが↓の2つめの図 https://web.archive.org/web/20230725185950/https://news.yahoo.co.jp/articles/6ca1c6739b46d8201f28467a56bfd773cc2332af 豪州は以下のページでdisease name:varicella zoster (shingles)です https://nindss.health.gov.au/pbi-dashboard/ 英国が↓にまとめ https://twitter.com/covidacc/status/1710136643670475132/photo/2 元データがこちら↓ https://www.gov.uk/government/publications/gp-in-hours-weekly-bulletins-for-2022 接種者や接種直後に微妙な客観的医療記録の増加があるかはそれが確認されたメタ解析も https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2232451 確認されなかったメタ解析も https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.29629?casa_token=vpluIDNnCLkAAAAA%3AFnn9R-w0288jz0apVwEhVuK5MUIr8UPs9xsjeaUgSPUqSd1QtuWezEcA3WPExdHOeuprQoF4lAV2Vvuw 存在します が、いずれにせよ帯状疱疹患者数は1つの要因で決まる訳ではなく総合すると上記各高接種先進国で患者が減少してます
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1840742496969842937
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1840857367061414138
- noteId - 1840857367061414138
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1727729572440
- tweetId - 1840742496969842937
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 帯状疱疹の患者数は複数の国地域でモニタリングされており日本を含め各先進国で21,22年共にコロナ禍前より減少しています 出典 日本の宮崎スタディが↓の2つめの図 https://web.archive.org/web/20230725185950/https://news.yahoo.co.jp/articles/6ca1c6739b46d8201f28467a56bfd773cc2332af 豪州は以下のページでdisease name:varicella zoster (shingles)です https://nindss.health.gov.au/pbi-dashboard/ 英国が↓にまとめ https://twitter.com/covidacc/status/1710136643670475132/photo/2 元データがこちら↓ https://www.gov.uk/government/publications/gp-in-hours-weekly-bulletins-for-2022 接種者や接種直後に微妙な客観的医療記録の増加があるかはそれが確認されたメタ解析も https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2232451 確認されなかったメタ解析も https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.29629?casa_token=vpluIDNnCLkAAAAA%3AFnn9R-w0288jz0apVwEhVuK5MUIr8UPs9xsjeaUgSPUqSd1QtuWezEcA3WPExdHOeuprQoF4lAV2Vvuw 存在します が、いずれにせよ帯状疱疹患者数は1つの要因で決まる訳ではなく総合すると上記各高接種先進国で患者が減少してます
Note Ratings
rated at | rated by | |
2024-09-30 19:46:55 -0500 | Rating Details | |
2024-09-30 19:23:28 -0500 | Rating Details | |
2024-09-30 19:18:30 -0500 | Rating Details | |
2024-09-30 19:14:40 -0500 | Rating Details | |
2024-09-30 19:07:40 -0500 | Rating Details | |
2024-09-30 18:58:45 -0500 | Rating Details | |
2024-09-30 18:58:04 -0500 | Rating Details | |
2024-09-30 18:56:46 -0500 | Rating Details | |
2024-09-30 18:50:33 -0500 | Rating Details | |
2024-09-30 18:46:04 -0500 | Rating Details | |
2024-09-30 18:45:39 -0500 | Rating Details | |
2024-09-30 18:37:13 -0500 | Rating Details | |
2024-09-30 18:36:29 -0500 | Rating Details | |
2024-09-30 18:34:04 -0500 | Rating Details | |
2024-09-30 18:33:47 -0500 | Rating Details | |
2024-09-30 18:23:28 -0500 | Rating Details | |
2024-09-30 18:14:33 -0500 | Rating Details | |
2024-09-30 18:14:23 -0500 | Rating Details | |
2024-09-30 18:13:56 -0500 | Rating Details | |
2024-09-30 18:13:12 -0500 | Rating Details | |
2024-09-30 18:12:36 -0500 | Rating Details | |
2024-09-30 18:12:33 -0500 | Rating Details | |
2024-09-30 18:12:05 -0500 | Rating Details | |
2024-09-30 18:06:34 -0500 | Rating Details | |
2024-09-30 18:01:46 -0500 | Rating Details | |
2024-09-30 17:44:56 -0500 | Rating Details | |
2024-09-30 17:43:28 -0500 | Rating Details | |
2024-09-30 17:42:18 -0500 | Rating Details | |
2024-09-30 17:39:28 -0500 | Rating Details | |
2024-09-30 17:33:35 -0500 | Rating Details | |
2024-09-30 17:33:30 -0500 | Rating Details | |
2024-09-30 17:31:05 -0500 | Rating Details | |
2024-09-30 17:29:17 -0500 | Rating Details | |
2024-09-30 17:26:42 -0500 | Rating Details | |
2024-09-30 17:24:11 -0500 | Rating Details | |
2024-09-30 17:23:59 -0500 | Rating Details | |
2024-09-30 17:15:52 -0500 | Rating Details | |
2024-09-30 17:15:31 -0500 | Rating Details | |
2024-09-30 17:11:38 -0500 | Rating Details | |
2024-09-30 17:09:23 -0500 | Rating Details | |
2024-09-30 17:08:15 -0500 | Rating Details | |
2024-09-30 17:06:11 -0500 | Rating Details | |
2024-09-30 17:05:32 -0500 | Rating Details | |
2024-09-30 17:00:54 -0500 | Rating Details | |
2024-09-30 16:53:30 -0500 | Rating Details | |
2024-09-30 16:53:25 -0500 | Rating Details | |
2024-09-30 16:50:12 -0500 | Rating Details | |
2024-09-30 16:49:48 -0500 | Rating Details | |
2024-09-30 16:49:21 -0500 | Rating Details | |
2024-09-30 16:47:08 -0500 | Rating Details | |
2024-09-30 16:44:46 -0500 | Rating Details | |
2024-09-30 16:43:27 -0500 | Rating Details | |
2024-09-30 16:42:02 -0500 | Rating Details | |
2024-09-30 16:34:29 -0500 | Rating Details | |
2024-09-30 16:34:11 -0500 | Rating Details | |
2024-09-30 16:33:21 -0500 | Rating Details | |
2024-09-30 16:33:06 -0500 | Rating Details | |
2024-09-30 16:32:50 -0500 | Rating Details | |
2024-09-30 16:32:44 -0500 | Rating Details | |
2024-09-30 16:32:01 -0500 | Rating Details | |
2024-09-30 16:31:46 -0500 | Rating Details | |
2024-09-30 16:30:53 -0500 | Rating Details | |
2024-09-30 16:27:42 -0500 | Rating Details | |
2024-09-30 16:23:56 -0500 | Rating Details | |
2024-09-30 16:23:24 -0500 | Rating Details | |
2024-09-30 16:10:10 -0500 | Rating Details | |
2024-09-30 16:08:20 -0500 | Rating Details | |
2024-09-30 16:02:01 -0500 | Rating Details | |
2024-09-30 16:00:27 -0500 | Rating Details | |
2024-09-30 15:56:11 -0500 | Rating Details | |
2024-09-30 15:55:41 -0500 | Rating Details | |
2024-10-02 18:44:18 -0500 | Rating Details | |
2024-10-02 18:00:13 -0500 | Rating Details | |
2024-10-01 17:53:57 -0500 | Rating Details | |
2024-10-01 16:16:57 -0500 | Rating Details | |
2024-10-01 10:08:47 -0500 | Rating Details | |
2024-10-01 05:47:07 -0500 | Rating Details | |
2024-10-01 05:34:04 -0500 | Rating Details | |
2024-10-01 04:03:26 -0500 | Rating Details | |
2024-10-01 03:31:10 -0500 | Rating Details | |
2024-10-01 03:27:29 -0500 | Rating Details | |
2024-10-01 03:16:18 -0500 | Rating Details | |
2024-10-01 03:14:28 -0500 | Rating Details | |
2024-10-01 03:10:01 -0500 | Rating Details | |
2024-10-01 01:06:48 -0500 | Rating Details | |
2024-10-01 01:03:29 -0500 | Rating Details | |
2024-10-01 00:45:17 -0500 | Rating Details | |
2024-10-01 00:25:04 -0500 | Rating Details | |
2024-09-30 23:40:38 -0500 | Rating Details | |
2024-09-30 23:29:15 -0500 | Rating Details | |
2024-09-30 23:26:33 -0500 | Rating Details | |
2024-09-30 23:25:40 -0500 | Rating Details | |
2024-09-30 23:00:06 -0500 | Rating Details | |
2024-09-30 22:50:20 -0500 | Rating Details | |
2024-09-30 22:35:13 -0500 | Rating Details | |
2024-09-30 22:23:12 -0500 | Rating Details | |
2024-09-30 22:00:40 -0500 | Rating Details | |
2024-09-30 21:56:02 -0500 | Rating Details | |
2024-09-30 21:43:34 -0500 | Rating Details | |
2024-09-30 21:35:24 -0500 | Rating Details | |
2024-09-30 21:28:56 -0500 | Rating Details | |
2024-09-30 21:28:06 -0500 | Rating Details | |
2024-09-30 21:17:57 -0500 | Rating Details | |
2024-09-30 20:35:58 -0500 | Rating Details | |
2024-09-30 20:25:03 -0500 | Rating Details | |
2024-09-30 20:22:00 -0500 | Rating Details | |
2024-09-30 20:17:32 -0500 | Rating Details | |
2024-09-30 20:09:37 -0500 | Rating Details | |
2024-10-01 20:41:28 -0500 | Rating Details | |
2024-10-01 11:33:15 -0500 | Rating Details | |
2024-10-01 04:17:59 -0500 | Rating Details | |
2024-10-01 03:08:59 -0500 | Rating Details | |
2024-10-01 03:05:59 -0500 | Rating Details | |
2024-10-01 02:55:14 -0500 | Rating Details | |
2024-10-01 01:20:53 -0500 | Rating Details | |
2024-10-01 01:16:23 -0500 | Rating Details | |
2024-09-30 23:08:35 -0500 | Rating Details | |
2024-09-30 20:20:27 -0500 | Rating Details | |
2024-09-30 20:15:03 -0500 | Rating Details | |
2024-09-30 20:13:48 -0500 | Rating Details | |
2024-09-30 20:07:47 -0500 | Rating Details | |
2024-10-11 06:33:40 -0500 | Rating Details | |
2024-10-01 00:14:10 -0500 | Rating Details | |
2024-09-30 23:43:48 -0500 | Rating Details | |
2024-09-30 19:26:51 -0500 | Rating Details | |
2024-09-30 18:14:05 -0500 | Rating Details | |
2024-09-30 17:33:45 -0500 | Rating Details | |
2024-09-30 16:56:34 -0500 | Rating Details | |
2024-10-02 19:49:03 -0500 | Rating Details | |
2024-10-02 08:11:06 -0500 | Rating Details | |
2024-10-01 04:47:00 -0500 | Rating Details | |
2024-10-01 02:23:06 -0500 | Rating Details |